Stefan Lethagen
Stockholm, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Post Hoc Analyses of A-SURE and PREVENT Confirm the Effectiveness of rFVIIIFc Prophylaxis Across All Ages, BMIs, Severities, and Inhibitor Histories.
Journal: TH open : companion journal to thrombosis and haemostasis
Published: February 27, 2026
A-SURE: intra-patient comparison of prophylactic effectiveness of a recombinant factor VIII Fc fusion protein versus standard half-life factor VIII in hemophilia A.
Journal: Hematology (Amsterdam, Netherlands)
Published: July 05, 2025
Evaluation of kidney function and damage in patients with hemophilia B-insights from the B-Natural study.
Journal: Research and practice in thrombosis and haemostasis
Published: June 24, 2025
Immune Tolerance Induction With a Recombinant Factor VIII Fc in Haemophilia A: Data From a Chart Review Study.
Journal: European journal of haematology
Published: January 24, 2025
Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries-Comparisons to Matched Controls.
Journal: Haemophilia : the official journal of the World Federation of Hemophilia
Published: November 20, 2024
Superior Prophylactic Effectiveness of a Recombinant FVIIIFc Over Standard Half-Life FVIII in Hemophilia A: A-SURE Study.
Journal: European journal of haematology
Published: July 08, 2024
Rescue immune tolerance induction with a recombinant factor Fc-fused VIII: prospective ReITIrate study of clinical, humoral and cellular immune responses.
Journal: Therapeutic advances in hematology
Published: February 29, 2024
Prophylaxis with a recombinant factor VIII Fc in hemophilia A: long-term follow-up on joint health, efficacy, and safety from phase 3 studies in children and adults.
Journal: Research and practice in thrombosis and haemostasis
Published: January 09, 2023
High use of pain, depression, and anxiety drugs in hemophilia: more than 3000 people with hemophilia in an 11-year Nordic registry study.
Journal: Research and practice in thrombosis and haemostasis
Published: August 25, 2022
Comment on "Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Insights from Pivotal and Extension Studies".
Journal: Seminars in thrombosis and hemostasis
Published: November 08, 2021
Last Updated: 09/26/2026